Carlisle (CSL) Q4 2025 earnings review

Profitability Slipped While Revenue Stalled

Carlisle ended 2025 with a thud rather than a bang. While revenue remained essentially flat (+0.4%), profitability deteriorated significantly. Adjusted EPS fell 13% YoY and Adjusted EBITDA margin compressed by 300 basis points to 22.1%. The divergence is stark: volume deleverage and 'strategic investments' are eating into margins faster than pricing or efficiency can offset them. While Management points to a 'resilient' re-roofing market, the growth story has paused.

๐Ÿ‚ Bull Case

Re-Roofing Foundation

The core Carlisle Construction Materials (CCM) segment saw revenue decline only 0.8% despite a difficult macro environment. With ~70% of this business tied to re-roofing, the floor is high even if new construction remains weak.

Capital Allocation Engine

Carlisle continues to aggressively return cash. The company repurchased $300M in shares in Q4 (totaling $1.3B for 2025) and plans another $1B buyback in 2026. Cash flow generation remains robust at $1.1B.

๐Ÿป Bear Case

Margin Erosion

Margins compressed significantly in both segments. CCM margins dropped 260 bps and Weatherproofing (CWT) margins collapsed 240 bps to 15.9%. Negative operating leverage is punishing the bottom line.

CWT Organic Weakness

While CWT reported 4% revenue growth, it was entirely fueled by M&A. Organic revenue actually fell 7%, signaling deep weakness in residential and new commercial construction markets.

โš–๏ธ Verdict: ๐Ÿ”ด

Bearish. The divergence between flat sales and double-digit profit declines is a red flag. Until organic volume stabilizes and margins stop compressing, the 'Vision 2030' targets look distant.

Key Themes

CONCERNNEW๐Ÿ”ด๐Ÿ”ด

Weatherproofing (CWT) Reality Check

The narrative of growth in the CWT segment masks a troubling reality. Reported revenue rose 4% only due to acquisitions (Plasti-Fab, ThermaFoam). Organic revenue plummeted 7% due to residential softness. More concerning is the profitability: Adjusted EBITDA dropped 10% and margins compressed to 15.9%.

CONCERN๐Ÿ”ด

Margin Compression Across the Board

Profitability is moving in the wrong direction. Consolidated Adjusted EBITDA margin fell 300 bps to 22.1%. Management attributes this to 'strategic investments' and volume declines. However, a drop of this magnitude suggests pricing power is not sufficient to offset overhead deleverage.

DRIVER๐ŸŸข

Aggressive Capital Returns

Management remains shareholder-friendly. In 2025, CSL returned $1.5B to shareholders ($1.3B buybacks + dividends). For 2026, they have authorized another $1B in buybacks. This financial engineering is crucial to supporting EPS while organic growth lags.

THEMEโšช

New Construction Headwinds

The macro environment remains hostile. New construction markets are 'working through the bottom of the cycle,' dragging down volumes. While re-roofing (70% of CCM) is stable, it cannot single-handedly generate growth without a pulse in new starts.

THEMENEWโšช

Vision 2030 Credibility Test

Management reiterated the 'Vision 2030' goal of $40 Adjusted EPS. With FY25 landing at $19.40 (down 4% YoY), the company needs to more than double earnings in the next 5 years. The current trajectory of declining earnings makes this target look increasingly ambitious.

Other KPIs

Adjusted EPS (25Q4)$3.90

Missed the trend of growth. Down 13% YoY from $4.47 in 24Q4. For the full year, EPS dropped 4% to $19.40, breaking the momentum seen in 2024.

Operating Cash Flow (25FY)$1.1 Billion

Stable. Cash flow remains the highlight, effectively funding the $1.3B in share repurchases. However, free cash flow conversion matters less if the core business isn't growing.

CCM Segment Revenue (25Q4)$827 Million

Stable (-0.8% YoY). This segment is the anchor. While it isn't growing, the high mix of re-roofing demand prevents the collapse seen in more cyclical peers.

Guidance

FY26 Revenue GrowthLow-Single-Digit %

Accelerating. Implies a shift from the flat/stagnant performance of 2025 to modest growth (likely ~2-4%). Management expects challenges to persist in H1 with improvement later.

FY26 Adj. EBITDA Margin+50 bps Expansion

Reversing. After contracting 220 bps in FY25 (to 24.4%), guidance calls for a rebound to ~24.9%. This relies on volume recovery and efficiency gains.

Key Questions

Organic Growth in CWT

CWT organic revenue fell 7% this quarter. When specifically do you expect organic growth to turn positive, independent of M&A contribution?

Margin Bridge

You guided for 50 bps margin expansion in 2026 after a 300 bps drop in Q4. What specific costs are falling off, or what volume assumptions underpin this quick reversal?

Vision 2030 Path

With FY25 EPS stepping back to $19.40, the CAGR required to hit $40 by 2030 has increased. Does the path rely more heavily on M&A now than it did a year ago?